Blog - Famicord Group

06 September 2024 Dr Tomasz Baran – FamiCord Vicepresident – speaks on cord blood banking at world’s largest cord blood conference Tomasz Baran, MD, MBA, Vice President of FamiCord Group, recently shared his expertise on cord blood banking at the world’s largest cord blood conference... Read more

15 July 2024 Expanison of cord blood stem cells as a chance for cancer patients Cord blood stem cells are used in medicine for treatment of over 80 different diseases such as leukemias, lymphomas and sickle cell anaemia for over 30 years. It has also been proven that... Read more

01 April 2024 New service available – Placenta banking FamiCord Group is excited to announce the international roll-out of this innovative service to new markets. In 2024, placenta banking... Read more

27 March 2024 Autologus cord blood in autism treatment – new clinical trial in Romania Researchers at Bioforum Foundation have been studying whether intravenous infusions of cord blood stem cells can help young children with autism spectrum disorder (ASD). Read more

20 March 2024 FamiCord and Vita 34 Vice president speaks on cord blood banking at Advanced Therapies conference in London Tomasz Baran, MD, MBA, Vice President of FamiCord Group and Vita 34, shared his expertise on the evolving field of cord blood... Read more

05 March 2024 FamiCord Group Central Laboratory with prestigous AABB accrediation The Central Laboratory of the FamiCord Group has achieved prestigious AABB accreditation for Cellular Starting Material (CSM), underscoring FamiCord's commitment to upholding the highest standards of quality and safety, as well as continuous improvement of procedures related to the preparation of co... Read more